PATENT CLAIM ANALYSIS

Application Number: 16026577
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "04400R"]

Abstract:
The present invention provides, among other things, methods of delivering mRNA in vivo, including administering to a subject in need of delivery a composition comprising an mRNA encoding a protein, encapsulated within a liposome such that the administering of the composition results in the expression of the protein encoded by the mRNA in vivo, wherein the liposome comprises a cationic lipid of formula I-c: or a pharmaceutically acceptable salt thereof.

Claim (Index 33):
The method of  claim 1 , wherein the mRNA comprises one or more modified nucleotides.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 95.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14521161', '15451312', '14521323', '15349720', '13662002']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8204669953553118
- 35 USC 102 Novelty (BERT): 0.6102226897384352
- Combined Prediction Score: 0.7994425647936242
- Mean Citation Score: 526.772714
- Max Citation Score: 725.2799
- Similarity Product: 459.7539247044682

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test